PlenOptika to Release QuickSee Wavefront Refractor

By

More Images
Product: QuickSee Wavefront Refractor
Top Line: PlenOptika, a biomedical technology company based in Allston, Mass., has completion the production process for the QuickSee Wavefront Refractor and plans to release the device in February. Upon final FDA registration and availability, PlenOptika’s QuickSee will be supplied to U.S. optometrists and other vision care professionals directly via Ethis HealthTech.
Close Up: With its compact design and fast, accurate measurements, the portable QuickSee Wavefront Refractor is designed to streamline the optometrists’ clinical workflow, declutter the practice environment, and improve patients’ experience.
The technology inside the QuickSee—upon final FDA registration, an FDA 510(k)-exempt Class I medical device—has been clinically evaluated in more than 1,200 eyes in five studies and documented in five peer-reviewed publications and conference abstracts.
Unlike conventional autorefractors, the QuickSee Wavefront Refractor uses wavefront aberrometry to precisely determine refractive errors, enabling highly accurate, objective measurements anywhere. The device combines the accuracy of gold-standard benchmarks with unmatched intuitive design that enables the simultaneous measurement of both eyes within 10 seconds, and will be offered at a highly economical price point. QuickSee features a binocular, open view design to help reduce instrument-induced myopia and a handheld, intuitive design that provides ease of use for optometrists.
The QuickSee offers workflow benefits, and its small footprint opens up possibilities for the use of other desktop devices in the lane. Its portability facilitates pediatric and elder-care applications.
“The QuickSee from PlenOptika checks all the boxes when I evaluate equipment,” said Bryan M. Rogoff, OD, MBA, an optometrist and optometric practice consultant specializing in best healthcare, business, and clinical operations practices. “Ease of use, quick, repeatable accuracy, portable, and price! With lower reimbursements, the QuickSee allows pretesting to be more efficient, which allows doctors to be more efficient. The Hartmann-Shack algorithms are quick and concise, and the innovative optics are able to obtain readings with patients that have 2.5mm to 7mm pupils (compared to larger equipment). And because of its compact design and price, the QuickSee is best utilized in the exam room, rather than a pretesting room, which creates less steps, and a better experience for the patient.”
Vital Stats:
• Enables eyecare professionals to perform measurements on both eyes within 10 seconds
• Costs 1/3 less than a conventional autorefractor
• Uses wavefront aberrometry to precisely determine refractive errors
• Features a binocular, open view to reduce instrument-induced myopia
• Calibration-free
• Works in any lighting condition
http://plenoptika.com; hello@plenoptika.com